![](/img/cover-not-exists.png)
HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin
Ahrén, Bo, Johnson, Susan L., Stewart, Murray, Cirkel, Deborah T., Yang, Fred, Perry, Caroline, Feinglos, Mark N.Volume:
37
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/dc14-0024
Date:
August, 2014
File:
PDF, 1.29 MB
english, 2014